Journey Medical Corporation (NASDAQ: DERM)
$5.5400
+0.3400 ( +7.16% ) 68.4K
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Market Data
Open
$5.5400
Previous close
$5.2000
Volume
68.4K
Market cap
$113.85M
Day range
$4.9400 - $5.6100
52 week range
$2.8500 - $8.1100
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Nov 12, 2024 |
10-q | Quarterly Reports | 91 | Nov 12, 2024 |
8-k | 8K-related | 15 | Nov 04, 2024 |
10-q | Quarterly Reports | 87 | Aug 13, 2024 |
8-k | 8K-related | 15 | Aug 12, 2024 |
4 | Insider transactions | 1 | Aug 01, 2024 |
4 | Insider transactions | 1 | Jul 23, 2024 |
4 | Insider transactions | 1 | Jul 23, 2024 |
3 | Insider transactions | 2 | Jul 19, 2024 |
8-k | 8K-related | 13 | Jul 12, 2024 |